The combined assay had higher sensitivity on T&P samples than on tumor samples from LUAD patients, and its AUC was significantly higher than those of individual SHOX2 and RASSF1A assays, respectively (DeLong test, P < 0.05) (Table 2; Figure 2B). The gene discussed is RASSF1; the disease is neoplasm.